Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo
K. Jimbow
Department of Dermatology, Sapporo Medical University School of Medicine, S-1, W-16, Chuo-ku, Sapporo 060-8543, Japan
Division of Dermatology and Cutaneous Sciences, Faculty of Medicine, University of Alberta, Edmonton, Canada
Search for more papers by this authorH. Chen
Division of Dermatology and Cutaneous Sciences, Faculty of Medicine, University of Alberta, Edmonton, Canada
Search for more papers by this authorJ-S. Park
Division of Dermatology and Cutaneous Sciences, Faculty of Medicine, University of Alberta, Edmonton, Canada
Search for more papers by this authorP.D. Thomas
Division of Dermatology and Cutaneous Sciences, Faculty of Medicine, University of Alberta, Edmonton, Canada
Search for more papers by this authorK. Jimbow
Department of Dermatology, Sapporo Medical University School of Medicine, S-1, W-16, Chuo-ku, Sapporo 060-8543, Japan
Division of Dermatology and Cutaneous Sciences, Faculty of Medicine, University of Alberta, Edmonton, Canada
Search for more papers by this authorH. Chen
Division of Dermatology and Cutaneous Sciences, Faculty of Medicine, University of Alberta, Edmonton, Canada
Search for more papers by this authorJ-S. Park
Division of Dermatology and Cutaneous Sciences, Faculty of Medicine, University of Alberta, Edmonton, Canada
Search for more papers by this authorP.D. Thomas
Division of Dermatology and Cutaneous Sciences, Faculty of Medicine, University of Alberta, Edmonton, Canada
Search for more papers by this authorAbstract
Background Vitiligo is a depigmenting disease of the skin, which may derive from programmed melanocyte death or destruction due to inherent sensitivity to oxidative stress arising from either toxic intermediates of melanin, a melanocyte-specific protein, or other sources. Tyrosinase-related protein (TRP) -1 has been shown to be involved not only in melanin biosynthesis but also in the prevention of premature melanocyte death in animals.
Objectives To clarify the biological role of human TRP-1 in melanocyte survival.
Methods Cultured melanocyte strains from an active advancing border of vitiligo were established and studied.
Results The established ‘vitiligo melanocytes’ showed large perikaryon and stubby dendrites. They showed early cell death when exposed to oxidative stress (ultraviolet B) and increased and abnormal immunostaining and immunoprecipitation by antibodies against human and mouse TRP-1, indicating an altered synthesis and processing of TRP-1. In pulse–chase and sequential immunoprecipitation experiments, vitiligo melanocytes revealed abnormal protein–protein interaction with calnexin, a melanogenesis-associated chaperone, suggesting altered folding and maturation of nascent TRP-1 polypeptides. Northern blot analysis indicated a decreased expression of TRP-1 mRNA, but heteroduplex analysis and verification of the mutation at the carboxy terminus of TRP-1 by restriction enzyme analysis did not show any abnormality.
Conclusions Our study suggests that the early cell death of vitiligo melanocytes is related to their increased sensitivity to oxidative stress, which may arise from complex processes of abnormal synthesis and processing of TRP-1 and its interaction with calnexin.
References
- 1 Lerner AB. Neural control of pigment cells. In: The Biology of Normal and Abnormal Melanocytes( T Kawamura, TB Fitzpatrick, M Seiji, eds). Tokyo: University of Tokyo Press, 1971: 3 – 16.
- 2 Haughton GK, Lipkin MR & Bystryn JC. Expression of vitiligo antigen on a revertant line of hamster melanoma cell. J Invest Dermatol 1984; 83: 317 – 19.
- 3 Grimes PE, Stockton T & Payne C et al. T cell profiles in vitiligo. J Am Acad Dermatol 1986; 14: 196 – 201.
- 4 Jimbow K. Vitiligo: therapeutic advances. Dermatol Clin 1998; 16: 399 – 407.
- 5 Jimbow K, Hara H & Vinayagamoorthy T et al. Molecular control of melanogenesis in malignant melanoma: functional assessment of tyrosinase and lamp gene families by UV exposure and gene co-transfection, and cloning of a cDNA encoding calnexin, a possible melanogenesis ‘chaperone’. J Dermatol 1994; 21: 894 – 906.
- 6 Jimbow K, Luo D & Chen H et al. Coordinated mRNA and protein expression of human LAMP-1 in induction of melanogenesis after UV-B exposure and co-transfection of human tyrosinase and TRP-1 cDNAs. Pigment Cell Res 1994; 7: 73 – 80.
- 7 Salopek TG & Jimbow K. Induction of melanogenesis during the various melanoma growth phases and the role of tyrosinase, lysosome-associated membrane proteins, and p90 calnexin in the melanogenesis cascade. J Invest Dermatol Symp Proc 1996; 1: 195 – 202.
- 8 Toyofuku K, Wada I & Hirosaki K et al. Involvement of calnexin in maturation of tyrosinase as a molecular chaperone. J Biochem 1999; 125: 82 – 9.
- 9 Sanchez-Ferrer A, Rodriguez-Lopez JN & Garcia-Canovas F et al. Tyrosinase: a comprehensive review of its mechanism. Biochim Biophys Acta 1995; 1247: 1 – 11.
- 10 Tsukamoto K, Jackson IJ & Urabe K et al. A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J 1992; 11: 519 – 26.
- 11 Jackson IJ, Chambers DM & Tsukamoto K et al. A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. EMBO J 1992; 11: 527 – 35.
- 12 Kobayashi T, Urabe K & Winder A et al. Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 1994; 13: 5818 – 25.
- 13 Bennett DC, Huszar D & Laipis PJ et al. Phenotypic rescue of mutant brown melanocytes by a retrovirus carrying a wild-type tyrosinase-related protein gene. Development 1990; 110: 471 – 5.
- 14 Jackson IJ, Chambers D & Rinchik EM et al. Characterization of TRP-1 mRNA levels in dominant and recessive mutations at the mouse brown (b) locus. Genetics 1990; 126: 451 – 9.
- 15 Vijayasaradhi S, Bouchard B & Houghton AN. The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product. J Exp Med 1990; 171: 1375 – 80.
- 16 Boissy RE, Sakai C & Zhao H et al. Human tyrosinase related protein-1 (TRP-1) does not function as a DHICA oxidase activity in contrast to murine TRP-1. Exp Dermatol 1998; 7: 198 – 204.
- 17 Johnson R & Jackson IJ. Light is a dominant mouse mutation resulting in premature cell death. Nat Genet 1992; 1: 226 – 9.
- 18 Hara H, Lee MH & Chen H et al. Role of gene expression and protein synthesis of tyrosinase, TRP-1, Lamp-1, and CD63 in UVB-induced melanogenesis in human melanomas. J Invest Dermatol 1994; 102: 495 – 500.
- 19 Luo D, Chen H & Jimbow K. Cotransfection of genes encoding human tyrosinase and tyrosinase-related protein-1 prevents melanocyte death and enhances melanin pigmentation and gene expression of Lamp-1. Exp Cell Res 1994; 213: 231 – 41.DOI: 10.1006/excr.1994.1195
- 20 Hearing VJ, Tsukamoto K & Urabe K et al. Functional properties of cloned melanogenic proteins. Pigment Cell Res 1992; 5: 264 – 70.
- 21 Kobayashi T, Imokawa G & Bennett DC et al. Tyrosinase stabilization by Tyrp1 (the brown locus protein). J Biol Chem 1998; 273: 31801 – 5.
- 22 Dakour J, Vinayagamoorthy T & Jimbow K et al. Identification of a cDNA coding for a Ca2+-binding phosphoprotein (p90), calnexin, on melanosomes in normal and malignant human melanocytes. Exp Cell Res 1993; 209: 288 – 300.DOI: 10.1006/excr.1993.1313
- 23 Austin LM & Boissy RE. Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. Am J Pathol 1995; 146: 1529 – 41.
- 24 Eisinger M & Marko O. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 1982; 79: 2018 – 22.
- 25 Herlyn M, Thurin J & Balaban G et al. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 1985; 45: 5670 – 6.
- 26 Bennett DC, Cooper PJ & Dexter TJ et al. Cloned mouse melanocyte lines carrying the germline mutations albino and brown: complementation in culture. Development 1989; 105: 379 – 85.
- 27 Der JE, Dixon WT & Jimbow K et al. A murine monoclonal antibody, MoAb HMSA-5, against a melanosomal component highly expressed in early stages, and common to normal and neoplastic melanocytes. Br J Cancer 1993; 67: 47 – 57.
- 28 Hearing VJ & Tsukamoto K. Enzymatic control of pigmentation in mammals. FASEB J 1991; 5: 2902 – 9.
- 29 Wada I, Ou WJ & Liu MC et al. Chaperone function of calnexin for the folding intermediate of gp80, the major secretory protein in MDCK cells. J Biol Chem 1994; 269: 7464 – 72.
- 30 Alena F, Iwashina T & Gili A et al. Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine. Cancer Res 1994; 54: 2661 – 6.
- 31 Shibahara S, Sato M & Muller RM et al. Structural organisation of the human heme oxygenase gene and the function of its promoter. Eur J Biochem 1989; 179: 557 – 63.
- 32 Boissy RE, Liu Y & Medrano EE et al. Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. J Invest Dermatol 1991; 97: 395 – 404.
- 33 Ou WJ, Cameron PH & Thomas DY et al. Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 1993; 364: 771 – 6.
- 34 Vijayasaradhi S, Xu Y & Bouchard B et al. Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, GP75. J Cell Biol 1995; 130: 807 – 20.
- 35 Lerner AB, Snell RS & Chanco-Turner ML et al. Vitiligo and sympathectomy. Arch Dermatol 1966; 94: 269 – 78.
- 36 Jimbow K, Szabo G & Fitzpatrick TB. Ultrastructural investigation of autophagocytosis of melanosomes and programmed death of melanocytes in White Leghorn feather: a study of morphogenetic events leading to hypomelanosis. Dev Biol 1974; 36: 8 – 23.
- 37 Maresca V, Roccella M & Roccella F et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997; 109: 310 – 13.
- 38 Schallreuter KU, Wood JM & Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991; 97: 1081 – 5.
- 39 Beazley WD, Gaze D & Panske A et al. Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol 1999; 141: 301 – 3.DOI: 10.1046/j.1365-2133.1999.02980.x
- 40 Schallreuter KU, Moore J & Wood JM et al. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Invest Dermatol Symp Proc 1999; 4: 91 – 6.
- 41 Hedley SJ, Metcalfe R & Gawkrodger DJ et al. Vitiligo melanocytes in long-term culture show normal constitutive and cytokine-induced expression of intercellular adhesion molecule-1 and major histocompatibility complex class I and class II molecules. Br J Dermatol 1998; 139: 965 – 73.
- 42 Le Poole IC & Van Den Wijngaard Rmjgj, Westerhof W et al. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 1993; 100: 816 – 22.
- 43 Jimenez M, Tsukamoto K & Hearing VJ. Tyrosinases from two different loci are expressed by normal and by transformed melanocytes. J Biol Chem 1991; 266: 1147 – 56.
- 44 Schreiber KL, Bell MP & Huntoon CJ et al. Class II histocompatibility molecules associate with calnexin during assembly in the endoplasmic reticulum. Int Immunol 1994; 6: 101 – 11.
- 45 Pind S, Riordan JR & Williams DB. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 1994; 269: 12784 – 8.
- 46 Fukuda M, Viitala J & Matteson J et al. Cloning of cDNAs encoding human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. J Biol Chem 1988; 263: 18920 – 8.
- 47 Schallreuter KU, Zschiesche M & Moore J et al. In vivo evidence for compromised phenylalanine metabolism in vitiligo. Biochem Biophys Res Commun 1998; 243: 395 – 9.DOI: 10.1006/bbrc.1997.8107